Form 4 for RNXT RenovoRx, Inc.
Accepted 2022-05-23 00:00:00 ET · period of report 2022-05-19 · accession 0001209191-22-031236 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-05-23 | 2022-05-19 | RNXT | Bagai Shaun | CEO, Dir | P - Purchase | $2.05 | +5,500 | 251.6K | +2% | +$11.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-19 | P | A | 5,500 | $2.05 | 251,557 | D | — | — | (F1) Includes 246,057 shares previously reported on a Form 3 filed on August 25, 2021 as a fully vested stock option exercisable at $0.15 per share. The option was exercised in full prior to the Issuer's initial public offering. |